Antioxidants in Antidiabetic Drugs May Fuel Cancer Spread, Mouse Study Shows (1 of 1) (IMAGE)

American Association for the Advancement of Science (AAAS)

Antioxidants in Antidiabetic Drugs May Fuel Cancer Spread, Mouse Study Shows (1 of 1)

Caption

Antioxidants are commonly used to treat patients with diabetes, a disease driven by oxidative stress. A new study in mice suggests that some antioxidant-containing diabetes medications may fuel cancer metastasis, raising concerns about their use in diabetic patients with cancer. This material relates to a paper that appeared in the 13 April, issue of Science Translational Medicine, published by AAAS. The paper, by H. Wang at Third Military Medical University in Chongqing, China, and colleagues was titled, "NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis."

Credit

https://pixabay.com/en/pill-yellow-isolated-316599/

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.